Patents by Inventor Byung Hak Yoon

Byung Hak Yoon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Composition for improving skin conditions, containing extracellular domain of human bone morphogenetic protein receptor 1a as active ingredient
    Patent number: 9452122
    Abstract: The present invention provides a composition for improving skin conditions, containing the extracellular domain of human bone morphogenetic protein receptor 1a as an active ingredient. The present invention contains the extracellular domain of human bone morphogenetic protein receptor 1a as an active ingredient inside a nanoliposome comprising hydrogenated lecithin as a constituent component, and the particle size is 50-250 nm. The composition of the present invention reduces wrinkles and alleviates atopic dermatitis. In addition, the present invention provides a method for improving skin conditions, comprising the step of administering a composition containing the extracellular domain of human bone morphogenetic protein receptor 1a as an active ingredient to a subject.
    Type: Grant
    Filed: August 30, 2012
    Date of Patent: September 27, 2016
    Assignee: JOINT CENTER FOR BIOSCIENCES
    Inventors: Zung Yoon Yang, Byung Hak Yoon, Seung-Hyon Choi
  • COMPOSITION FOR IMPROVING SKIN CONDITIONS, CONTAINING EXTRACELLULAR DOMAIN OF HUMAN BONE MORPHOGENETIC PROTEIN RECEPTOR 1a AS ACTIVE INGREDIENT
    Publication number: 20140335155
    Abstract: The present invention provides a composition for improving skin conditions, containing the extracellular domain of human bone morphogenetic protein receptor 1a as an active ingredient. The present invention contains the extracellular domain of human bone morphogenetic protein receptor 1a as an active ingredient inside a nanoliposome comprising hydrogenated lecithin as a constituent component, and the particle size is 50-250 nm. The composition of the present invention reduces wrinkles and alleviates atopic dermatitis. In addition, the present invention provides a method for improving skin conditions, comprising the step of administering a composition containing the extracellular domain of human bone morphogenetic protein receptor 1a as an active ingredient to a subject.
    Type: Application
    Filed: August 30, 2012
    Publication date: November 13, 2014
    Applicant: JOINT CENTER FOR BIOSCEINCES
    Inventors: Zung Yoon Yang, Byung Hak Yoon, Seung-Hyon Choi